
Journal of Medicinal Chemistry p. 2158 - 2164 (1988)
Update date:2022-07-30
Topics:
Desai
Fowler
Chorvat
Frederick
Hatley
Rorig
Garthwaite
Analogues of the dibasic antiarrhythmic agent disobutamide (2) were prepared and evaluated for antiarrhythmic efficacy, myocardial depression, and anticholinergic activity. The replacement of an isopropyl group in disobutamide by an acetyl group led to the monoclasic analogue SC-40230, 7a, which demonstrated good antiarrhythmic activity accompanied by less myocardial depressant and anticholinergic activities. In addition, it did not induce clear cytoplasmic vacuoles as did the parent compound. SC-40230 was chosen from among other analogues as a candidate for clinical evaluation. Other compounds prepared and evaluated included indolizidinones and a secondary amine isomer of disobutamide.
View MoreImprove Medical Technology(Nanxiong) Co., Ltd
Contact:86-751-3836997
Address:No.33, Pingan First Road, Fine Chemical Industry Base, Nanxiong City, Shaoguan, Guangdong, China
Jinan Jianfeng Chemical Co., Ltd
Contact:0086-531-88110457
Address:sales01(-a-t-)pharmachemm{dot}c+o+m
Zhejiang Linhai Xinhua Chemicals Factory
Contact:0086-13661858911
Address:Xunqiao Development Zone, Linhai, Zhejiang, China
Ningbo Tide Imp. & Exp. Co., Ltd.
Contact:+86-571-8993 7933; +86-571-8993 6453
Address:7/F Anno Domini Building, Tower South, 8 Qiu Shi Road,Hangzhou,China.
Contact:86-27-84888681
Address:Wuhan economic & technology development zone
Doi:10.3184/030823408X314725
(2008)Doi:10.1016/j.ica.2021.120493
(2021)Doi:10.1039/DT9870002669
(1987)Doi:10.1021/ja01315a052
(1935)Doi:10.1016/S0008-6215(02)00397-X
(2003)Doi:10.1016/S0040-4020(01)83459-1
(1987)